Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-10-09 4:15 pm Purchase | 2025-10-02 | 13G | CRESCENT BIOPHARMA, INC CBIO | TANG CAPITAL MANAGEMENT, LLC | 700,000 5.040% | 700,000 (New Position) | Filing History |
| 2025-09-23 8:34 pm Purchase | 2025-09-16 | 13G | PMV PHARMACEUTICALS INC PMVP | TANG CAPITAL MANAGEMENT, LLC | 4,720,357 8.900% | 4,720,357 (New Position) | Filing History |
| 2025-09-19 4:15 pm Sale | 2025-09-17 | 13D | HILLEVAX INC HLVX | TANG CAPITAL MANAGEMENT, LLC | 0 0.000% | -4,920,000 (Position Closed) | Filing History |
| 2025-09-03 4:15 pm Sale | 2025-08-29 | 13D | ITEOS THERAPEUTICS INC. ITOS | TANG CAPITAL MANAGEMENT, LLC | 10,000 100.000% | -3,816,692 (-99.74%) | Filing History |
| 2025-08-21 4:15 pm Sale | 2025-08-19 | 13D | CARGO THERAPEUTICS INC CRGX | TANG CAPITAL MANAGEMENT, LLC | 10,000 100.000% | -3,049,630 (-99.67%) | Filing History |
| 2025-08-14 4:15 pm Sale | 2025-06-30 | 13G | BOLT BIOTHERAPEUTICS, INC BOLT | TANG CAPITAL MANAGEMENT, LLC | 166,879 8.700% | -23,760 (-12.46%) | Filing History |
| 2025-08-14 4:15 pm Purchase | 2025-06-30 | 13G | COMPASS THERAPEUTICS INC CMPX | TANG CAPITAL MANAGEMENT, LLC | 13,496,208 9.800% | 2,443,576 (+22.11%) | Filing History |
| 2025-08-14 4:15 pm Purchase | 2025-06-30 | 13G | CYTOMX THERAPEUTICS INC CTMX | TANG CAPITAL MANAGEMENT, LLC | 11,065,662 7.000% | 4,347,837 (+64.72%) | Filing History |
| 2025-08-14 4:15 pm Sale | 2025-06-30 | 13G | ELEVATION ONCOLOGY INC ELEV | TANG CAPITAL MANAGEMENT, LLC | 3,115,000 4.997% | -2,928,921 (-48.46%) | Filing History |
| 2025-08-14 4:15 pm Sale | 2025-06-30 | 13G | OUTLOOK THERAPEUTICS INC P OTLK | TANG CAPITAL MANAGEMENT, LLC | 1,500,000 3.400% | -400,000 (-21.05%) | Filing History |
| 2025-08-14 4:15 pm Sale | 2025-06-30 | 13G | REVIVA PHARMACEUTICALS HLDGS C RVPH | TANG CAPITAL MANAGEMENT, LLC | 169,999 4.800% | -25,516 (-13.05%) | Filing History |
| 2025-07-30 4:15 pm Unchanged | 2025-07-30 | 13G | ESSA PHARMA INC EPIX | TANG CAPITAL MANAGEMENT, LLC | 4,300,000 9.700% | 0 (Unchanged) | Filing History |
| 2025-07-22 4:31 pm Unchanged | 2025-07-18 | 13D | ITEOS THERAPEUTICS INC. ITOS | TANG CAPITAL MANAGEMENT, LLC | 3,826,692 9.990% | 0 (Unchanged) | Filing History |
| 2025-07-09 4:44 pm Purchase | 2025-07-07 | 13D | CARGO THERAPEUTICS INC CRGX | TANG CAPITAL MANAGEMENT, LLC | 3,059,630 6.600% | 330,342 (+12.10%) | Filing History |
| 2025-06-12 4:27 pm Unchanged | 2025-06-11 | 13D | ITEOS THERAPEUTICS INC. ITOS | TANG CAPITAL MANAGEMENT, LLC | 3,826,692 9.990% | 0 (Unchanged) | Filing History |
| 2025-05-23 4:15 pm Sale | 2025-05-21 | 13D | ACELYRIN INC SLRN | TANG CAPITAL MANAGEMENT, LLC | 0 0.000% | -8,824,693 (Position Closed) | Filing History |
| 2025-05-19 4:15 pm Sale | 2025-05-15 | 13D | ALLAKOS INC ALLK | TANG CAPITAL MANAGEMENT, LLC | 10,000 100.000% | -8,683,687 (-99.88%) | Filing History |
| 2025-05-15 4:15 pm Purchase | 2025-03-31 | 13G | ALX ONCOLOGY HLDGS INC ALXO | TANG CAPITAL MANAGEMENT, LLC | 3,158,265 5.900% | 3,158,265 (New Position) | Filing History |
| 2025-05-15 4:15 pm Purchase | 2025-03-31 | 13G | BOLT BIOTHERAPEUTICS, INC BOLT | TANG CAPITAL MANAGEMENT, LLC | 190,639 9.900% | 190,639 (New Position) | Filing History |
| 2025-05-15 4:15 pm Purchase | 2025-03-31 | 13G | COMPASS THERAPEUTICS INC CMPX | TANG CAPITAL MANAGEMENT, LLC | 11,052,632 8.000% | 3,652,632 (+49.36%) | Filing History |